Podofilox
NDC 0574-0621, Podofilox, gel, from Padagis US LLC.
- Product NDC
- 0574-0621
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211871
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PODOFILOX5 mg/g
Pharmacologic classes
Decreased Mitosis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-0621-05 | 00574062105 | 3.5 g in 1 TUBE, WITH APPLICATOR (0574-0621-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d2e70c5e-d4a9-4295-9eff-517ffb974e61NADAC price for package 00574062105
GET /v1/drugs/nadac/00574062105
Use it
Look up 0574-0621 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-0621. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.